San Diego-based Viking Therapeutics marked itself as a serious competitor while in the weight loss drug current market in February just after revealing promising facts from the mid-phase trial of experimental drug VK2735, which prompt it rivaled—and outperformed—Novo and Lilly drugs when supplied for a weekly injection As well as in March the c